Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gerbing RB"" wg kryterium: Autor


Tytuł:
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Autorzy:
Sorrell AD
Alonzo TA
Hilden JM
Gerbing RB
Loew TW
Hathaway L
Barnard D
Taub JW
Ravindranath Y
Smith FO
Arceci RJ
Woods WG
Gamis AS
Sorrell, April D
Alonzo, Todd A
Hilden, Joanne M
Gerbing, Robert B
Loew, Thomas W
Hathaway, Lois
Barnard, Dorothy
Pokaż więcej
Źródło:
Cancer (0008543X); Oct2012, Vol. 118 Issue 19, p4806-4814, 9p
Czasopismo naukowe
Tytuł:
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Cooper TM
Franklin J
Gerbing RB
Alonzo TA
Hurwitz C
Raimondi SC
Hirsch B
Smith FO
Mathew P
Arceci RJ
Feusner J
Iannone R
Lavey RS
Meshinchi S
Gamis A
Cooper, Todd M
Franklin, Janet
Gerbing, Robert B
Alonzo, Todd A
Hurwitz, Craig
Pokaż więcej
Źródło:
Cancer (0008543X); Feb2012, Vol. 118 Issue 3, p761-769, 9p
Czasopismo naukowe
Tytuł:
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Autorzy:
Lange BJ
Yang RK
Gan J
Hank JA
Sievers EL
Alonzo TA
Gerbing RB
Sondel PM
Lange, Beverly J
Yang, Richard K
Gan, Jacek
Hank, Jaquelyn A
Sievers, Eric L
Alonzo, Todd A
Gerbing, Robert B
Sondel, Paul M
Pokaż więcej
Źródło:
Pediatric Blood & Cancer; Sep2011, Vol. 57 Issue 3, p398-405, 8p
Czasopismo naukowe
Tytuł:
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Autorzy:
Park JR
Villablanca JG
London WB
Gerbing RB
Haas-Kogan D
Adkins ES
Attiyeh EF
Maris JM
Seeger RC
Reynolds CP
Matthay KK
Park, Julie R
Villablanca, Judith G
London, Wendy B
Gerbing, Robert B
Haas-Kogan, Daphne
Adkins, E Stanton
Attiyeh, Edward F
Maris, John M
Seeger, Robert C
Pokaż więcej
Źródło:
Pediatric Blood & Cancer; Jan2009, Vol. 52 Issue 1, p44-50, 7p
Czasopismo naukowe
Tytuł:
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy.
Autorzy:
Leger KJ; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States.
Robison N; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States.
Narayan HK; Division of Cardiology, Department of Pediatrics, Rady Children's Hospital San Diego, University of California San Diego, La Jolla, CA, United States.
Smith AM; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Tsega T; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Chung J; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Daniels A; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Chen Z; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Englefield V; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Demissei BG; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Lefebvre B; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Morrow G; Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, GA, United States.
Dizon I; Division of Cardiology, Seattle Children's Hospital, Seattle, WA, United States.
Gerbing RB; Children's Oncology Group, Monrovia, CA, United States.
Pabari R; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Getz KD; Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Pollard JA; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.
Chow EJ; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States.; Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Tang WHW; Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, United States.
Border WL; Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, GA, United States.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Sachdeva R; Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, GA, United States.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Alonzo TA; Children's Oncology Group, Monrovia, CA, United States.; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, DE, United States.
Cooper TM; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States.
Ky B; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Pokaż więcej
Źródło:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Dec 01; Vol. 10, pp. 1286241. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Autorzy:
Hoff FW; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Qiu Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brown BD; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gerbing RB; COG Statistics and Data Center, Monrovia, California, USA.
Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA.
Alonzo TA; COG Statistics and Data Center, Monrovia, California, USA.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jenkins GN; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA.
Horton TM; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA.
Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Proteomics. Clinical applications [Proteomics Clin Appl] 2023 Nov; Vol. 17 (6), pp. e2200109. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Cycle Proteins*/genetics
Cell Cycle Proteins*/metabolism
Endoplasmic Reticulum Chaperone BiP*
Child ; Humans ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Bortezomib/metabolism ; Protein Serine-Threonine Kinases/metabolism ; Unfolded Protein Response ; Valosin Containing Protein/genetics ; Valosin Containing Protein/metabolism
Czasopismo naukowe
Tytuł:
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Autorzy:
Stevens AM; Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
Horton TM; Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
Glasser CL; Division of Pediatric Hematology/Oncology, NYU Langone Hospital - Long Island, Mineola, NY, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Alonzo TA; Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, USA.
Redell MS; Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2023 Mar; Vol. 40 (2), pp. 147-158. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
Interleukin-10*/therapeutic use
Leukemia, Myeloid, Acute*/drug therapy
Adult ; Humans ; Child ; Tumor Necrosis Factor-alpha ; Interleukin-6/therapeutic use ; Prognosis ; Cytokines ; Recurrence
Czasopismo naukowe
Tytuł:
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Autorzy:
Hoff FW; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Van Dijk AD; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Qiu Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Hu CW; Department of Bioengineering, Rice University, Houston, TX, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Ligeralde A; Biophysics, University of California, Berkeley, CA, USA.
Jenkins GN; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Gerbing RB; University of Southern California, Los Angeles, CA, USA.
Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders, Emory University, Atlanta GA, USA.
Alonzo TA; University of Southern California, Los Angeles, CA, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Qutub AA; Department of Biomedical Engineering, The University of Texas at San Antonio, USA;.
De Bont ESJM; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Horton TM; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Kornblau SM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2022 Oct 01; Vol. 107 (10), pp. 2329-2343. Date of Electronic Publication: 2022 Oct 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Proteomics*
Bortezomib ; Child ; Humans ; Prognosis ; Protein Array Analysis ; Proteins
Czasopismo naukowe
Tytuł:
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Autorzy:
Huang BJ; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. .; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. .
Smith JL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Farrar JE; University of Arkansas for Medical Sciences & Arkansas Children's Research Institute, Little Rock, AR, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Umeda M; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ries RE; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Leonti AR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Crowgey E; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Furlan SN; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Tarlock K; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Armendariz M; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Liu Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Shaw TI; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wei L; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Cooper TM; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Gamis AS; Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Aplenc R; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Klco JM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Triche T Jr; Van Andel Research Institute, Grand Rapids, MI, USA.
Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Sep 19; Vol. 13 (1), pp. 5487. Date of Electronic Publication: 2022 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Profiling*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Biomarkers ; Child ; Humans ; Neoplastic Stem Cells ; RNA ; Recurrence
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies